Assessing the Efficacy, Safety, and Tolerability of Met DR in Subjects With T2DM Over 12 Weeks
Clinical trial NCT01819272 · COMPLETED
Trial details
- NCT number
- NCT01819272
- Sponsor
- Elcelyx Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-01
- Primary completion
- 2013-09-01
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.